Banchereau; Jacques F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Banchereau; Jacques F..The latest application filed is for "fusion proteins comprising an anti-cd40 antibody and cancer antigens".

Company Profile

7.45.92

Banchereau; Jacques F. - Montclair NJ
Banchereau; Jacques F - Montclair NJ
Banchereau; Jacques F. - Dallas TX US
Banchereau; Jacques F. - Montchair NJ
Banchereau; Jacques F. - Ecully FR
Banchereau, Jacques F - Dallas TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions and methods for the systemic treatment of arthritis Grant 11,406,688 - Banchereau , et al. August 9, 2	2022-08-09
Nucleic acids encoding anti-CD40 antibodies Grant 11,267,895 - Banchereau , et al. March 8, 2	2022-03-08
Fusion Proteins Comprising An Anti-cd40 Antibody And Cancer Antigens App 20210308242 - ZURAWSKI; Gerard ; et al.	2021-10-07
Fusion Proteins Comprising An Anti-cd40 Antibody And Hiv Antigenic Peptides App 20210221904 - ZURAWSKI; Gerard ; et al.	2021-07-22
Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptides Grant 10,988,544 - Zurawski , et al. April 27, 2	2021-04-27
Fusion proteins comprising an anti-CD40 antibody and cancer antigens Grant 10,980,869 - Zurawski , et al. April 20, 2	2021-04-20
Anti-cd40 Antibodies And Uses Thereof App 20210024641 - Banchereau; Jacques F. ; et al.	2021-01-28
Compositions and Methods for the Systemic Treatment of Arthritis App 20200345813 - Banchereau; Jacques F. ; et al.	2020-11-05
Compositions and methods for the systemic treatment of arthritis Grant 10,716,832 - Banchereau , et al.	2020-07-21
Anti-CD40 antibodies Grant 10,683,361 - Banchereau , et al.	2020-06-16
Anti-cd40 Antibodies And Uses Thereof App 20190085088 - Banchereau; Jacques F. ; et al.	2019-03-21
Method of making an anti-CD40 antibody Grant 10,087,256 - Banchereau , et al. October 2, 2	2018-10-02
Methods and compositions for treating breast cancer with dendritic cell vaccines Grant 10,023,841 - Palucka , et al. July 17, 2	2018-07-17
Antigen Presenting Cell Targeted Vaccines App 20180094071 - Zurawski; Gerard ; et al.	2018-04-05
Dendritic cell vaccines Grant 9,862,927 - Banchereau , et al. January 9, 2	2018-01-09
Antigen Presenting Cell Targeted Cancer Vaccines App 20180000916 - Zurawski; Gerard ; et al.	2018-01-04
Compositions and Methods for the Systemic Treatment of Arthritis App 20170281730 - Banchereau; Jacques F. ; et al.	2017-10-05
Compositions and methods for the systemic treatment of arthritis Grant 9,649,361 - Banchereau , et al. May 16, 2	2017-05-16
Anti-cd40 Antibodies And Uses Thereof App 20170114142 - Banchereau; Jacques F. ; et al.	2017-04-27
Anti-CD40 antibodies Grant 9,567,401 - Banchereau , et al. February 14, 2	2017-02-14
Anti-CD40 antibodies Grant 9,562,104 - Banchereau , et al. February 7, 2	2017-02-07
Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1) Grant 9,339,556 - Banchereau , et al. May 17, 2	2016-05-17
Vaccines directed to langerhans cells Grant 9,315,580 - Banchereau , et al. April 19, 2	2016-04-19
Compositions and Methods for the Systemic Treatment of Arthritis App 20160067310 - Banchereau; Jacques F. ; et al.	2016-03-10
Antigen Presenting Cell Targeted Cancer Vaccines App 20160022792 - Zurawski; Gerard ; et al.	2016-01-28
Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Grant 9,234,040 - Zurawski , et al. January 12, 2	2016-01-12
Methods And Compositions For Treating Breast Cancer With Dendritic Cell Vaccines App 20150368612 - Palucka; Anna Karolina ; et al.	2015-12-24
Blood Transcriptional Signatures Of Active Pulmonary Tuberculosis And Sarcoidosis App 20150315643 - O'Garra; Anne ; et al.	2015-11-05
Antigen Presenting Cell Targeted Vaccines App 20150299329 - Zurawski; Gerard ; et al.	2015-10-22
Dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/Nef Grant 9,109,011 - Banchereau , et al. August 18, 2	2015-08-18
Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Grant 9,102,730 - Zurawski , et al. August 11, 2	2015-08-11
Fusion proteins comprising antibody and HPV E6 and E7 antigens Grant 9,102,734 - Zurawski , et al. August 11, 2	2015-08-11
Controlling allergy and asthma by activating human DCs via Dectin-1 or toll-like receptor 2 (TLR2) Grant 9,045,542 - Oh , et al. June 2, 2	2015-06-02
Early Detection Of Tuberculosis Treatment Response App 20150133469 - O'Garra; Anne ; et al.	2015-05-14
Enhancement Of Pathogen-specific Memory Th17 Cell Responses App 20150064205 - Oh; SangKon ; et al.	2015-03-05
Anti-CD40 targeted fusion proteins Grant 8,961,991 - Zurawski , et al. February 24, 2	2015-02-24
Compositions and Methods for the Systemic Treatment of Arthritis App 20140364327 - Banchereau; Jacques F. ; et al.	2014-12-11
Therapeutic Applications Of Activation Of Human Antigen-presenting Cells Through Dectin-1 App 20140322214 - Banchereau; Jacques F. ; et al.	2014-10-30
Anti-cd40 Antibodies And Uses Thereof App 20140234344 - Banchereau; Jacques F. ; et al.	2014-08-21
Agents That Engage Antigen-presenting Cells Through Dendritic Cell Asialoglycoprotein Receptor (dc-asgpr) App 20140227268 - Banchereau; Jacques F. ; et al.	2014-08-14
Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) Grant 8,728,481 - Banchereau , et al. May 20, 2	2014-05-20
Vaccines Based On Targeting Antigen To Dcir Expressed On Antigen-presenting Cells App 20140134168 - Zurawski; Gerard ; et al.	2014-05-15
Activation Of Human Antigen-presenting Cells Through Dendritic Cell Lectin-like Oxidized Ldl Receptor-1 (lox-1) App 20140120617 - BANCHEREAU; JACQUES F. ; et al.	2014-05-01
Blood Transcriptional Signature Of Active Versus Latent Mycobacterium Tuberculosis Infection App 20140080732 - Banchereau; Jacques F. ; et al.	2014-03-20
Vaccines Directed To Langerhans Cells App 20140030264 - Banchereau; Jacques F. ; et al.	2014-01-30
Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Grant 8,586,052 - Zurawski , et al. November 19, 2	2013-11-19
Vaccines Based On Targeting Antigen To Dcir Expressed On Antigen-presenting Cells App 20130295120 - Zurawski; Gerard ; et al.	2013-11-07
Fusion protein with HIV antigen Grant 8,518,410 - Zurawski , et al. August 27, 2	2013-08-27
Unique Transcriptional Signatures In The Blood Of Clinical Responders App 20130183346 - Palucka; Anna Karolina ; et al.	2013-07-18
Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1) Grant 8,481,314 - Banchereau , et al. July 9, 2	2013-07-09
Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Grant 8,449,888 - Zurawski , et al. May 28, 2	2013-05-28
Dendritic Cells Loaded With Heat Shocked Melanoma Cell Bodies App 20130122049 - Palucka; Anna Karolina ; et al.	2013-05-16
Reprogramming Immune Environment In Breast Cancer Via Dendritic Cells App 20130064855 - Palucka; Anna Karolina ; et al.	2013-03-14
CONTROLLING ALLERGY AND ASTHMA BY ACTIVATING HUMAN DCs VIA DECTIN-1 OR TOLL-LIKE RECEPTOR 2 (TLR2) App 20130052193 - Oh; SangKon ; et al.	2013-02-28
Dendritic Cell (dc)-vaccine Therapy For Pancreatic Cancer App 20130028915 - Palucka; Anna Karolina ; et al.	2013-01-31
Immunoglobulin-like Transcript (ilt) Receptors As Cd8 Antagonists App 20120315269 - Klechevsky; Eynav ; et al.	2012-12-13
SLE-DC-MEDIATED ENHANCED IgG- AND IgA-SECRETING B CELL RESPONSES App 20120308578 - Oh; SangKon ; et al.	2012-12-06
Compositions And Methods To Immunize Against Hepatitis C Virus App 20120301465 - Dutartre; Helene ; et al.	2012-11-29
Agents that Engage Antigen-Presenting Cells Through Dendritic Cell Asialoglycoprotein Receptor (DC-ASGPR) App 20120282281 - Banchereau; Jacques F. ; et al.	2012-11-08
Dendritic Cells (DCs) Targeting for Tuberculosis (TB) Vaccine App 20120244155 - Lecine; Patrick ; et al.	2012-09-27
Novel Vaccine Adjuvants Based on Targeting Adjuvants to Antibodies Directly to Antigen-Presenting Cells App 20120231023 - Zurawski; Gerard ; et al.	2012-09-13
Diagnostic and Therapeutic Uses for B Cell Maturation Antigen App 20120213768 - Oh; SangKon ; et al.	2012-08-23
Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) Grant 8,236,934 - Banchereau , et al. August 7, 2	2012-08-07
Compositions And Methods Of Alteration Of Autoimmune Diseases App 20120177597 - Ueno; Hideki ; et al.	2012-07-12
Enhancement of Pathogen-Specific Memory Th17 Cell Responses App 20120128710 - Oh; SangKon ; et al.	2012-05-24
Targeting Antigens to Human Dendritic Cells Via DC-Asialoglycoprotein Receptor to Produce IL-10 Regulatory T-Cells App 20120121592 - Oh; SangKon ; et al.	2012-05-17
Novel Vaccine Adjuvants Based On Targeting Adjuvants To Antibodies Directly To Antigen-presenting Cells App 20120039916 - Zurawski; Gerard ; et al.	2012-02-16
Il-18 Receptor As A Novel Target Of Regulatory T Cells In Cancer App 20120027674 - Ueno; Hideki ; et al.	2012-02-02
Thymic Stromal Lymphopoietin (TSLP) and OX40 Ligand in Cancer App 20120020960 - Palucka; Anna Karolina ; et al.	2012-01-26
Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Grant 8,057,798 - Zurawski , et al. November 15, 2	2011-11-15
Dendritic Cell Immunoreceptors (dcir)-mediated Crosspriming Of Human Cd8+ T Cells App 20110274653 - Banchereau; Jacques F. ; et al.	2011-11-10
Use Of Allogeneic Cell Lines To Load Antigen-presenting Cells To Elicit Or Eliminate Immune Responses App 20110268767 - Banchereau; Jacques F. ; et al.	2011-11-03
Methods to Reduce B-Helper T Cells to Treat Autoimmune Diseases App 20110243938 - Ueno; Hideki ; et al.	2011-10-06
Blood Transcriptional Signature Of Mycobacterium Tuberculosis Infection App 20110196614 - Banchereau; Jacques F. ; et al.	2011-08-11
Use of allogeneic cell lines to load antigen presenting cells to elicit or eliminate immune responses Grant 7,988,963 - Banchereau , et al. August 2, 2	2011-08-02
Dendritic Cell Vaccines App 20110182937 - Banchereau; Jacques F. ; et al.	2011-07-28
Blood Transcriptional Signature Of Active Versus Latent Mycobacterium Tuberculosis Infection App 20110129817 - Banchereau; Jacques F. ; et al.	2011-06-02
Vaccines Directed To Langerhans Cells App 20110081343 - Banchereau; Jacques F. ; et al.	2011-04-07
Anti-interferon alpha monoclonal antibodies and methods for use Grant 7,888,481 - Banchereau , et al. February 15, 2	2011-02-15
Monoclonal antibodies to human CTLA-8 (IL-17A) Grant 7,879,980 - Golstein , et al. February 1, 2	2011-02-01
Antigen Presenting Cell Targeted Cancer Vaccines App 20100322929 - Zurawski; Gerard ; et al.	2010-12-23
Antigen Presenting Cell Targeted Vaccines App 20100297114 - Zurawski; Gerard ; et al.	2010-11-25
Antigen Presenting Cell Targeted Anti-viral Vaccines App 20100291082 - Zurawski; Gerard ; et al.	2010-11-18
Anti-cd40 Antibodies And Uses Thereof App 20100239575 - Banchereau; Jacques F. ; et al.	2010-09-23
Hiv Vaccine Based On Targeting Maximized Gag And Nef To Dendritic Cells App 20100135994 - Banchereau; Jacques F. ; et al.	2010-06-03
Systemic Lupus Erythematosus Diagnostic Assay App 20100113293 - Pascual; Maria Virginia ; et al.	2010-05-06
Diagnosis of Metastatic Melanoma and Monitoring Indicators of Immunosuppression Through Blood Leukocyte Microarray Analysis App 20100076691 - Palucka; Anna Karolina ; et al.	2010-03-25
Respiratory Syncytial Virus Renders Dendritic Cells Tolerogenic App 20100061965 - CONNOLLY; JOHN E. ; et al.	2010-03-11
Anti-cd8 Antibodies Block Priming Of Cytotoxic Effectors And Lead To Generation Of Regulatory Cd8+ T Cells App 20090304659 - Banchereau; Jacques F. ; et al.	2009-12-10
Compositions and methods for the systemic treatment of arthritis Grant 7,622,110 - Banchereau , et al. November 24, 2	2009-11-24
Systemic lupus erythematosus diagnostic assay Grant 7,608,395 - Pascual , et al. October 27, 2	2009-10-27
Methods for Treating Autoimmune Diseases in a Subject and In Vitro Diagnostic Assays App 20090263474 - Banchereau; Jacques F. ; et al.	2009-10-22
Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays Grant 7,544,357 - Banchereau , et al. June 9, 2	2009-06-09
Activation of Human Antigen-Presenting Cells Through Dendritic Cell Lectin-Like Oxidized LDL Receptor-1 (LOX-1) App 20080267984 - Banchereau; Jacques F. ; et al.	2008-10-30
Activation of Human Antigen-Presenting Cells Through CLEC-6 App 20080254047 - Banchereau; Jacques F. ; et al.	2008-10-16
Vaccines Based on Targeting Antigen to DCIR Expressed on Antigen-Presenting Cells App 20080241170 - Zurawski; Gerard ; et al.	2008-10-02
Therapeutic Applications of Activation of Human Antigen-Presenting Cells Through Dectin-1 App 20080233140 - Banchereau; Jacques F. ; et al.	2008-09-25
Gene Expression In Peripheral Blood Mononuclear Cells From Children With Diabetes App 20080227709 - Pascual; Maria Virginia ; et al.	2008-09-18
Agents That Engage Antigen-Presenting Cells Through Dendritic Cell Asialoglycoprotein Receptor (DC-ASGPR) App 20080206262 - Banchereau; Jacques F. ; et al.	2008-08-28
Gene Expression Signatures in Blood Leukocytes Permit Differential Diagnosis of Acute Infections App 20080171323 - Banchereau; Jacques F. ; et al.	2008-07-17
Anti-Interferon Alpha Monoclonal Antibodies and Methods for Use App 20080160030 - Banchereau; Jacques F. ; et al.	2008-07-03
Compositions and Methods for the Systemic Treatment of Arthritis App 20080161262 - Banchereau; Jacques F. ; et al.	2008-07-03
Compositions and Methods for the Systemic Treatment of Arthritis App 20080160032 - Banchereau; Jacques F. ; et al.	2008-07-03
Compositions and Methods for the Systemic Treatment of Arthritis App 20080161424 - Banchereau; Jacques F. ; et al.	2008-07-03
Dendritic Cells Loaded with Heat Shocked Melanoma Cell Bodies App 20080112924 - Palucka; Anna Karolina ; et al.	2008-05-15
Dendritic Cells Generated Using GM-CSF and Interferon Alpha and Loaded with Heat-Treated and Killed Cancer Cells App 20080031900 - Palucka; Anna Karolina ; et al.	2008-02-07
Diagnosis, prognosis and monitoring of disease progression of systemic lupus erythematosus through blood leukocyte microarray analysis App 20070238094 - Chaussabel; Damien ; et al.	2007-10-11
Compositions and methods for the treatment of cancer App 20070237763 - Banchereau; Jacques F. ; et al.	2007-10-11
Module-Level Analysis of Peripheral Blood Leukocyte Transcriptional Profiles App 20070231816 - Chaussabel; Damien ; et al.	2007-10-04
Compositions And Methods For The Treatment Of Cancer App 20070202106 - Palucka; Anna Karolina ; et al.	2007-08-30
Diagnosis of systemic onset juvenile idiopathic arthritis through blood leukocyte microarray analysis App 20070134690 - Pascual; Maria Virginia ; et al.	2007-06-14
Oncohumouse App 20070118914 - Banchereau; Jacques F. ; et al.	2007-05-24
Systemic lupus erythematosus diagnostic assay App 20070059717 - Pascual; Marla Virginia ; et al.	2007-03-15
Immune response assessment method App 20060051358 - Banchereau; Jacques F. ; et al.	2006-03-09
Adjuvants and processes to induce a specific type of immune response Grant 6,818,221 - Pulendran , et al. November 16, 2	2004-11-16
Method of treating malignancies through induction of blood immune responses App 20040087532 - Banchereau, Jacques F. ; et al.	2004-05-06
Adjuvants and processes to induce a specific type of immune response App 20040082538 - Pulendran, Bali ; et al.	2004-04-29
Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays App 20040067232 - Banchereau, Jacques F. ; et al.	2004-04-08
Compositions and methods for producing antigen-presenting cells App 20040022761 - Banchereau, Jacques F ; et al.	2004-02-05
Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays App 20020160974 - Banchereau, Jacques F. ; et al.	2002-10-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.